TNSN89015A1 - Carbamates de [(5(6)(1h-azol-1-ylmethyl) benzimidazole] - Google Patents

Carbamates de [(5(6)(1h-azol-1-ylmethyl) benzimidazole]

Info

Publication number
TNSN89015A1
TNSN89015A1 TNTNSN89015A TNSN89015A TNSN89015A1 TN SN89015 A1 TNSN89015 A1 TN SN89015A1 TN TNSN89015 A TNTNSN89015 A TN TNSN89015A TN SN89015 A TNSN89015 A TN SN89015A TN SN89015 A1 TNSN89015 A1 TN SN89015A1
Authority
TN
Tunisia
Prior art keywords
azol
carbamates
benzimidazole
ylmethyl
helminths
Prior art date
Application number
TNTNSN89015A
Other languages
English (en)
Inventor
Herman Margaretha Raeymaekers Alfons
Jean Edgard Freyne Eddy
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of TNSN89015A1 publication Critical patent/TNSN89015A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

CARBAMATES DE [(5(6)(1H-AZOL-L-YLETHYL)BENZIMIDAZOLE]. L'INVENTION A POUR OBJET DES DERIVES NOUVEAUX QUI SONT DES CARBAMATES DE [(5(6)(1H-AZOL-L-YLMETHYL) BENZIMIDAZOLE] POSSEDANT UNE ACTIVITE ANTHELMINTHIQUE ; DES COMPOSITIONS CONTENANT LESDITS COMPOSES A TITRE D'INGREDIENT ACTIF ET UN PROCEDE POUR COMBATTRE LA CROISSANCE DES HELMINTHES
TNTNSN89015A 1988-02-12 1989-02-10 Carbamates de [(5(6)(1h-azol-1-ylmethyl) benzimidazole] TNSN89015A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/155,464 US4826862A (en) 1988-02-12 1988-02-12 Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates

Publications (1)

Publication Number Publication Date
TNSN89015A1 true TNSN89015A1 (fr) 1991-02-04

Family

ID=22555544

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN89015A TNSN89015A1 (fr) 1988-02-12 1989-02-10 Carbamates de [(5(6)(1h-azol-1-ylmethyl) benzimidazole]

Country Status (17)

Country Link
US (1) US4826862A (fr)
EP (1) EP0328203A3 (fr)
JP (1) JPH01228986A (fr)
CN (1) CN1022245C (fr)
AU (1) AU605406B2 (fr)
DK (1) DK64089A (fr)
FI (1) FI890654A (fr)
IL (1) IL89249A (fr)
MA (1) MA21493A1 (fr)
MY (1) MY104979A (fr)
NO (1) NO172438C (fr)
NZ (1) NZ227801A (fr)
PH (1) PH27056A (fr)
PT (1) PT89659B (fr)
SU (1) SU1706389A3 (fr)
TN (1) TNSN89015A1 (fr)
ZA (1) ZA891079B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943574A (en) * 1987-06-01 1990-07-24 Janssen Pharmaceutica N.V. (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
US5039677A (en) * 1987-06-01 1991-08-13 Janssen Pharmaceutica N.V. 6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles
US5072453A (en) * 1990-03-08 1991-12-17 Nathaniel Widder Body protection system
US5374615A (en) * 1990-10-31 1994-12-20 E. R. Squibb & Sons, Inc. Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives
PH31175A (en) * 1990-10-31 1998-03-20 Squibb & Sons Inc Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
GB9115272D0 (en) * 1991-07-15 1991-08-28 Pfizer Ltd Benzimidazole anthelmintics
GB9115273D0 (en) * 1991-07-15 1991-08-28 Pfizer Ltd Benzimidazole anthelmintics
DE4142731A1 (de) * 1991-12-21 1993-06-24 Hoechst Ag Biozide polymerisate und polymerisatdispersionen, verfahren zu ihrer herstellung und ihre verwendung
GB9205368D0 (en) * 1992-03-12 1992-04-22 Pfizer Ltd Benzimidozole anthelmintic agents
US5278181A (en) * 1992-05-12 1994-01-11 Board Of Regents Acting On Behalf Of The University Of Michigan Soluble alkyl[5-[amino (phenyl)methyl]-1H-benzimidazol-2-yl] carbamate anthelmintics
US20040170735A2 (en) * 2002-04-05 2004-09-02 Mcneil-Ppc, Inc. Methods and compositions for altering the sweetness delivery profile of sucralose
US20040086605A1 (en) * 2002-10-30 2004-05-06 Sox Thomas E. Composition for delivering a high intensity sweetener
WO2004099744A2 (fr) * 2003-05-02 2004-11-18 Sensitech Inc. Procedes et appareil pour l'indication d'evenements lies a des conditions thermiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US3969526A (en) * 1973-05-29 1976-07-13 Smithkline Corporation Anthelmintic 5-heterocycliothio and oxy-2-carbalkoxyaminobenzimidazles
US4512998A (en) * 1980-10-20 1985-04-23 Schering Corporation Anthelmintic benzimidazole carbamates
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
MA21493A1 (fr) 1989-10-01
IL89249A0 (en) 1989-09-10
PT89659B (pt) 1994-02-28
US4826862A (en) 1989-05-02
DK64089D0 (da) 1989-02-10
EP0328203A2 (fr) 1989-08-16
CN1022245C (zh) 1993-09-29
NO890579D0 (no) 1989-02-10
JPH01228986A (ja) 1989-09-12
DK64089A (da) 1989-08-13
FI890654A0 (fi) 1989-02-10
CN1036014A (zh) 1989-10-04
EP0328203A3 (fr) 1990-03-14
NO890579L (no) 1989-08-14
NO172438B (no) 1993-04-13
NO172438C (no) 1993-07-21
SU1706389A3 (ru) 1992-01-15
ZA891079B (en) 1990-10-31
AU605406B2 (en) 1991-01-10
FI890654A (fi) 1989-08-13
PH27056A (en) 1993-02-01
IL89249A (en) 1993-03-15
AU2966589A (en) 1989-08-17
MY104979A (en) 1994-07-30
PT89659A (pt) 1989-10-04
NZ227801A (en) 1990-10-26

Similar Documents

Publication Publication Date Title
TNSN89015A1 (fr) Carbamates de [(5(6)(1h-azol-1-ylmethyl) benzimidazole]
DE69939165D1 (de) N,n-disubstituierte amide welche die bindung von integrinen an ihre rezeptoren hemmen
MX9801716A (es) Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
TNSN97015A1 (fr) Nouveaux derives de 19-nor-pregnene.
DE60037726D1 (de) Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
ATE202337T1 (de) Cyclopropylalkansäurederivate
FR2526271B1 (fr) Composition herbicide contenant un derive de 1, 2, 4-triazole a titre d'ingredient actif
ES8802421A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
ES2033985T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica.
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
DE60014369D1 (de) Propansäurederivate, die die bindung von integrinen an ihre rezeptoren behindern
PT1057826E (pt) Derivados carboxamidicos dimericos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem
FR2559151B1 (fr) Derives de l'arginine et sels d'addition d'acides correspondants pharmaceutiquement acceptables et compositions pharmaceutiques les contenant
FI880548A (fi) Menetelmä farmakologisesti aktiivisten 2-amino-N-(1,2-difenyylietyyli)asetamidijohdannaisten valmistamiseksi
NO913118D0 (no) T-pa pro stabilisering.
MX9207543A (es) Sales estables de acido (+)-(1s,2r)-[[b.(2-hidroxilamino-2-oxoetil)-n-metilamino]carbonil]cicl ohexan-1-carboxilico, procedimiento para su preparacion, y composiciones farmaceuticas que las contienen
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina
IT8321704A0 (it) Derivato idrosolubile del1-(2-idrossietil)-2-metil-5-nitroimidazolo ad attivita' terapeutica, procedimento per la sua preparazione e relative composizioni farmaceutiche
FR2552082B1 (fr) 2,5-disubstituees-4(3h)-pyrimidones ayant une activite antagoniste receptrice histamine h2, compositions pharmaceutiques contenant de tels composes a titre d'ingredients actifs et procede de preparation de ceux-ci
IT8522788A0 (it) Derivati dell'acido (trifluorometil)-fenossibenzoico, procedimento per la loro preparazione e fungicidi che contengono questi composti come principio attivo.
EP0178176A3 (en) Tetrahydro-1,2,4-oxadiazine-5-thione derivatives
FR2738488B1 (fr) Composition contenant a titre de principe actif au moins un extrait d'au moins une iridacee
EP0127090A3 (fr) Inhibiteurs d'enzymes transformant l'angiotensine
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene
ITMI922832A1 (it) DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.